entertainment -WSS

entertainment

author：knowledge 2025-10-01 04:10:42 - browse：767

WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies.

The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages. Fifty-seven percent of hospital pharmacists said they are facing critical shortages of chemotherapy drugs in a new survey from the American Society of Health-System Pharmacists. Hospital pharmacists also reported significant shortages of steroids, hormonal drugs, and oral liquids such as amoxicillin and lidocaine.

Yet industry and patient representatives who have met with task force members said there has been no indication of when they will make recommendations that could spur federal agencies to act and steer the debate in Congress.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Quicker fix for pulse oximeters urged during FDA public meeting

explore

WSS

FDA drug safety: Singulair case shows systemic surveillance flaws

Biden administration opens offers in Medicare drug price negotiations

Intellia reports positive results for its CRISPR

At ASCO, AstraZeneca reports strong data for breast cancer drug

ARCH Venture Partners is raising $3 billion for a life sciences fund

FDA's Pazdur wants cancer trials to range beyond China alone

leisure time

entertainment

entertainment

Jerome Adams on the need for new antivirals for Covid

Ultragenyx gene therapy for rare liver ailment succeeds in late

Activists slam private health insurers over coverage restrictions

Cognito secures funding to test medical device for Alzheimer's

ChatGPT in medicine: STAT answers readers' burning questions

Shifting the focus from loneliness to social health

Moonlake's readout produced a cash windfall. Risks remain

ARCH Venture Partners is raising $3 billion for a life sciences fund

As demand for Covid shots wanes, Moderna seeks its next success

Congressmen charge Covid hearing ‘could have been an email’

hotspot

Commercial surrogacy can be ethical, despite pope’s claims

At ASCO, AstraZeneca reports strong data for breast cancer drug

SAMSHA loosens regulations on methadone treatment centers

Woman returns to dialysis after doctors remove transplanted pig kidney

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

See how much Covid

hotspot

focus

explore

entertainment